[ TRANSACTION RECORD ]

JPMorgan Chase & Co. Investment in Seagen Inc. — 2023

VERIFIED VECTOR ID: 002134 · tx-230
M SOURCE NODE — FUNDER
JPMorgan Chase & Co.
Finance United States
$43,000,000,000
EQUITY
14/12/2023
Q DESTINATION NODE — RECIPIENT
Seagen Inc.
Company United States
Amount (USD)
$43.0B
Flow Type
EQUITY
Transaction Date
14/12/2023
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity JPMorgan Chase & Co.
AUM 3900000
HQ Location United States
Sector Finance
Recipient Profile [ Q ]
Entity Seagen Inc.
Entity Type Company
Jurisdiction United States
Intelligence Note

Pfizer Inc. finalized the 43 billion dollar acquisition of Seagen to establish a world-class oncology division focused on targeted cancer medicines and antibody-drug conjugates. This transaction is one of the largest in biotech history and significantly expands Pfizer’s therapeutic pipeline. The deal represents a massive institutional deployment of capital into oncology.

Σ
Primary Forensic Source https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-seagen/
✓ SOURCE LINKED